相关实验视频
Updated: Jun 10, 2025

09:39
In Vivo Imaging of Dauer-specific Neuronal Remodeling in C. elegans
Published on: September 4, 2014
11.3K
野生类型C. elegans的DAF-2激酶和与dauer相关的突变体的催化活动
Harini Krishnan1, Sultan Ahmed1, Stevan R Hubbard2
1Department of Physiology and Biophysics, School of Medicine, Stony Brook University, NY, USA.
The FEBS journal
|October 21, 2024
概括
在Caenorhabditis elegans中,DAF-2胰岛素受体激酶酸化特定的氨酸基因,类似于人类受体. 突变的DAF-2激酶在体外显示功能完全丧失,为C. elegans生理学提供了洞察力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- DAF-2是Caenorhabditis elegans胰岛素受体的同源,调节关键的生理过程,如发育,新陈代谢,应激反应和寿命.
- DAF-2通路与人体胰岛素/IGF-1信号通路高度保持一致,使其成为研究人类疾病的有价值模型.
- 存在众多的daf-2突变等位基因,促进对其调节机制的遗传研究.
研究的目的:
- 生物化学描述野生型DAF-2的激酶域,包括其催化活性和基质特异性.
- 调查突变DAF-2激酶的功能,对应于C. elegans中已知的功能丧失等位基因.
- 为了比较DAF-2激酶与人体胰岛素/IGF-1受体激酶的酶特性.
主要方法:
- 野生类型和突变DAF-2的激酶域的表达和净化.
- 在体外激酶试验中,使用基质测定基质特异性.
- 测试小分子抑制剂林西替尼对DAF-2激酶活性的抑制作用.
主要成果:
- 在YxN和YxxM基因内,DAF-2激酶化氨酸残留物,类似于人类胰岛素受体激酶.
- C端的酸化表明DAF-2受体具有潜在的独立信号传导能力.
- 与人体胰岛素或IGF-1受体激酶不同,DAF-2激酶表现出林西替尼的弱抑制.
- 突变的DAF-2激酶与部分功能丧失等位基因相对应,在体外显示完全丧失激酶活性.
结论:
- 生物化学表征为DAF-2激酶功能和基质特异性提供了新的见解.
- 该研究强调了C. elegans DAF-2和人类胰岛素/IGF-1受体之间的抑制剂敏感性差异.
- 这些发现有助于理解C. elegans生理学中的DAF-2信号,并为研究其他突变提供基础.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K

